Torsten Kuiper

Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.

C. Calonder, A. Deodhar, G. Schett, 2021, Pharmacology & therapeutics.